Catalog Number 821731C |
Device Problem
Appropriate Term/Code Not Available (3191)
|
Patient Problems
High Blood Pressure/ Hypertension (1908); Nausea (1970); Tachycardia (2095)
|
Event Date 07/04/2023 |
Event Type
Injury
|
Event Description
|
A facility reported an accidental injection of radio contrast medium into the sampling/injection site of the ventricular shunt device in place of the vascular access.The contrast product was therefore injected into the cerebral ventricles.Patient presented with nausea, hypertension, tachycardia.The patient is an adult of approximately 60 years-old.The following days : general tonico-clonic crisis and hydrocephalus meningitis at pseudomonas & candida, septic vasculitis, ischemic stroke + appearance of stenosis.Long term: cognitive problems, left hypoesthesia, total dependence, continence and swallowing problems.Actions taken in the healthcare establishment to manage the patient: immediate management by the intensive care unit team.Patient has incapacitating sequela.
|
|
Manufacturer Narrative
|
An investigation has been initiated based on the reported information.Upon completion of the investigation, a follow-up report will be submitted.Other "health effect-clinical code" 2223, 3272, 2389, 4418, 2263, 2551, 2352, 1815.
|
|
Manufacturer Narrative
|
The eds drainage system was not returned for evaluation and lot number information has not been provided; therefore, an evaluation of the device could not be performed, and device history record (dhr) could not be reviewed.The root cause(s) of the reported issue is due to user¿s error, failure to adhere to ifu warning label regarding using the needle free sampling/injection site.If additional relevant information becomes available in the future, this complaint will be reopened, and the respective evaluation performed.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.A medical assessment was requested to our medical safety department with the following conclusion: use error.Failure to adhere to ifu label regarding using the needle-free sampling/injection site."warning" the eds3 system provides direct access to the ventricular drainage catheter via the patient line stopcock and the needle-free injection site.Care must be taken when administering medication through these locations to minimize the chance of intravascular medications being injected into the cerebrospinal fluid.".
|
|
Search Alerts/Recalls
|
|